- Home
- RNA vs OPP Comparison
RNA vs OPP Comparison
Compare RNA & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | OPP |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.5M | 190.4M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | OPP |
|---|---|---|
| Price | $12.34 | $7.66 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $69.26 | N/A |
| AVG Volume (30 Days) | ★ 127.8K | 73.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | N/A |
| Revenue Next Year | $18.11 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.13 | $7.47 |
| 52 Week High | $73.06 | $8.77 |
Technical Indicators
Market Signals| Indicator | RNA | OPP |
|---|---|---|
| Relative Strength Index (RSI) | 51.20 | 49.32 |
| Support Level | $11.95 | $7.50 |
| Resistance Level | $14.05 | $8.03 |
| Average True Range (ATR) | 0.39 | 0.09 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 80.33 | 38.89 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.